FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称OLORINAB
异名/同义词(1AS,5AS)-2-(4-OXY-PYRAZIN-2-YL)-1A,2,5,5A-TETRAHYDRO-1H-2,3-DIAZA-CYCLOPROPA(A)PENTALENE-4-CARBOXYLIC ACID ((S)-1-HYDROXYMETHYL-2,2-DIMETHYL-PROPYL)-AMIDE
(4AS,5AS)-N-((2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL)-1-(4-OXIDOPYRAZIN-2-YL)-4,4A,5,5A-TETRAHYDRO-1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE
1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE, 4,4A,5,5A-TETRAHYDRO-N-((1S)-1-(HYDROXYMETHYL)-2,2-DIMETHYLPROPYL)-1-(4-OXIDO-2-PYRAZINYL)-, (4AS,5AS)-
APD371
APD-371
OLORINAB
OLORINAB [INN]
OLORINAB [USAN]
OLORINAB [WHO-DD]
CAS登记号1268881-20-4
物质唯一标识(Unique Ingredient Identifier)581F7DFA9B
分子式C18H23N5O3
国际化合物标识(International Chemical Identifier,InChI)ACSQLTBPYZSGBA-GMXVVIOVSA-N
SMILES[C@]12(c3c(C[C@@]1(C2)[H])c(nn3-c4ncc[n+](c4)[O-])C(N[C@H](CO)C(C)(C)C)=O)[H]
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System